Last year mTNBC poster had Tecentriq. I pointed out it was pulled from market around mid-way through our trial. Due to all LL/ICI were alive 5 yrs later, was evidence Leronlimab improves the "any ICI" Dr. J reference & it is leverage Cytodyn will not "give away".
For me Mrs. Peterson validates my repeated blabble of i would not chase ICI market 1st, being Cytodyn/LL is the sequencing cornerstone. All ICI will be improved post-LL dosing.
Dr. J has known "any ICI", being MD Anderson ran LL/ICI combos in the past for Cytodyn.
ICI's will get consolidated.
___
“She’s been cancer-free ever since,” Les Peterson said.
Wina Peterson’s side effects have been nearly nonexistent.
She is still taking both drugs today.
___
“We’re scared to quit,” Les Peterson said.
Said nobody ever about chemo or radiation.
Dr. J said off the cuff LL/ICI could maybe eliminate need for chemo
___
* The Petersons hope more people can get access to the drug.
“It’s a miracle to me,” Wina Peterson said. “I thought I was going to die sooner than later.”
___
No pharma on the planet is anywhere close to having a mix of Alive / Well & NED survivors @ 5+ years
A sequencing miracle @ that....
___
Mrs. Peterson started dosing 2019.
Leronlimab has brought a drugs (Tecentriq), horrible SAE toxicities, to a non-existent level.
Absolutely unheard of
___
In the US -- low dose aspirin kills 1k yearly, due to shock. Btw don't forget, the FcRn formulas have anti-anphalaxtic
Have always posted/linked why, Leronlimab is safer than aspirin. (It was followed by typically being ridiculed)
Now, Leronlimab historically shows allowing low dosing of a toxic cancer drug for years, to be affective AND safer than aspirin.
Absolutely stunning.
___
We have:
*HIV-MDR
*HIV stand alone
*Stand Alone agent
*Prime n Pair agent
*Cold tumors to Hot
*Keytruda synergistic
*Tecentriq synergistic
*Radiation synergistic
*Temezlomide synergy
*T-cell pathway restored
*Lady of Leronlimab #9 dosed @ Keytruda 2025
( not remiss of potentials in: Alzheimer’s, LATCH, Glioblastoma, Liver mets, Prostate, Pancreatic, Lung, Sarcoma, Urothelial Cancers,mTNBC expansion )
March 2026:
News of LL has allowed low combo dosing with a highly toxic mTNBC drug, (Tecentriq) to be both safe AND affective as of 7 years .....
April 2026:
1st official mCRC data will be historical.
Partnership potential mentioned several times.
Fully funded to 2027 for current & planned trials.